Cary J. Claiborne - 05 Dec 2024 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Executive Officer, Director
Signature
/s/ Cary J. Claiborne
Issuer symbol
ADIL
Transactions as of
05 Dec 2024
Net transactions value
$0
Form type
4
Filing time
05 Dec 2024, 17:47:13 UTC
Previous filing
27 Mar 2024
Next filing
02 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option (Right to Buy) Award $0 +350,000 $0.000000 350,000 05 Dec 2024 Common Stock 350,000 $1.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing December 5, 2024.